GRTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 6.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Galera Therapeutics Insider Trading History Chart

Galera Therapeutics Share Price & Price History

^$0.04

+0.30 (1.20%)

As of 11/22/2024 01:00 AM ET

Days: 30 | 90 | 365

From Porter & Company | Ad

The AI boom is just getting started. And the real wealth has still to be made…

You must read this new presentation from Porter Stansberry.

Galera Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/16/2023	Mark Bachleda	Insider	Buy	11,000	$2.25	$24,750.00	11,000
3/13/2023	Chris Degnan	CFO	Buy	10,000	$1.96	$19,600.00	10,000
3/10/2023	Mel Sorensen	CEO	Buy	100,000	$1.68	$168,000.00	332,044
12/17/2021	Linda West	Director	Buy	20,000	$2.74	$54,800.00

Bill Gates’s Next Big AI Bet: Stargate

From Brownstone Research | Ad

In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.

I believe we are about to do it again with this new AI project called Stargate

SEC Filings (Institutional Ownership Changes) for Galera Therapeutics (NASDAQ:GRTX)

50.77% of Galera Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Galera Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/3/2024	GSA Capital Partners LLP	3,632,627	$0.51M	0.0%	-6.7%	6.679%
1/31/2024	abrdn plc	898,374	$0.13M	0.0%	N/A	1.652%
8/11/2023	Sectoral Asset Management Inc.	2,005,054	$6.26M	1.0%	-4.5%	4.673%
8/4/2023	Parallel Advisors LLC	7,867	$25K	0.0%	N/A	0.018%
8/2/2023	Baystate Wealth Management LLC	47,695	$0.15M	0.0%	N/A	0.111%
7/27/2023	Pinnacle Associates Ltd.	47,695	$0.15M	0.0%	N/A	0.111%
7/24/2023	Vontobel Holding Ltd.	20,000	$62K	0.0%	N/A	0.047%
7/21/2023	Global Assets Advisory LLC	24,500	$73K	0.1%	N/A	0.057%
7/11/2023	Good Life Advisors LLC	11,250	$35K	0.0%	N/A	0.026%
5/12/2023	Sectoral Asset Management Inc.	2,098,565	$5.37M	1.0%	+25.9%	4.891%
5/12/2023	Mirabella Financial Services LLP	57,000	$6.66M	1.0%	N/A	0.133%
5/1/2023	Virtu Financial LLC	20,195	$52K	0.0%	N/A	0.047%
4/14/2023	Raymond James Financial Services Advisors Inc.	23,475	$60K	0.0%	N/A	0.055%
2/10/2023	Sectoral Asset Management Inc.	1,666,666	$2.48M	0.5%	N/A	5.848%
8/12/2022	Ensign Peak Advisors Inc	151,777	$0.20M	0.0%	+281.6%	0.566%
2/11/2022	Ensign Peak Advisors Inc	39,775	$0.15M	0.0%	N/A	0.150%
2/10/2022	Acadian Asset Management LLC	96,027	$0.44M	0.0%	N/A	0.363%
2/8/2022	Raymond James Financial Services Advisors Inc.	22,311	$0.10M	0.0%	-26.3%	0.084%
1/28/2022	Taylor Wealth Management Partners	11,635	$53K	0.0%	-79.9%	0.044%
1/25/2022	Belvedere Trading LLC	96,486	$0.26M	0.0%	N/A	0.365%
11/17/2021	Altium Capital Management LP	300,605	$2.44M	0.5%	+36.7%	1.137%
11/15/2021	Marshall Wace LLP	83,050	$0.67M	0.0%	-28.7%	0.315%
11/12/2021	AIGH Capital Management LLC	2,036,495	$16.50M	3.5%	+0.7%	7.724%
10/26/2021	Taylor Wealth Management Partners	58,012	$0.47M	0.2%	-11.0%	0.220%
9/22/2021	Nan Fung Group Holdings Ltd	613,223	$6.03M	1.9%	N/A	2.326%
8/25/2021	Marshall Wace LLP	116,508	$1.15M	0.0%	+115.3%	0.442%
8/17/2021	Worth Venture Partners LLC	469,174	$4.61M	1.7%	+119.0%	1.779%
8/17/2021	Millennium Management LLC	118,548	$1.17M	0.0%	N/A	0.450%
8/17/2021	Bridgeway Capital Management LLC	110,000	$1.08M	0.0%	+22.2%	0.417%
8/16/2021	State Street Corp	15,964	$0.16M	0.0%	-87.5%	0.061%
8/16/2021	Tibra Equities Europe Ltd	36,900	$0.36M	0.1%	N/A	0.140%
8/16/2021	Marshall Wace LLP	116,508	$1.15M	0.0%	+115.3%	0.442%
8/13/2021	Renaissance Technologies LLC	24,170	$0.24M	0.0%	-34.8%	0.092%
8/13/2021	Northern Trust Corp	14,795	$0.15M	0.0%	-84.4%	0.056%
8/13/2021	Altium Capital Management LP	219,900	$2.16M	0.5%	N/A	0.834%
8/13/2021	Jump Financial LLC	18,000	$0.18M	0.0%	N/A	0.071%
8/13/2021	Geode Capital Management LLC	71,256	$0.70M	0.0%	-38.7%	0.282%
8/13/2021	Vanguard Group Inc.	481,524	$4.73M	0.0%	-4.9%	1.907%
8/12/2021	AIGH Capital Management LLC	2,022,889	$19.89M	3.6%	+121.7%	8.010%
8/12/2021	Trexquant Investment LP	11,237	$0.11M	0.0%	N/A	0.044%
8/12/2021	JPMorgan Chase & Co.	35,973	$0.35M	0.0%	+52.1%	0.142%
8/12/2021	Ergoteles LLC	40,000	$0.39M	0.0%	N/A	0.158%
8/11/2021	BlackRock Inc.	185,141	$1.82M	0.0%	-68.7%	0.733%
8/11/2021	Deutsche Bank AG	275,935	$2.71M	0.0%	+4,367.1%	1.093%
8/5/2021	US Bancorp DE	10,579	$0.10M	0.0%	N/A	0.042%
6/10/2021	Perceptive Advisors LLC	254,664	$2.25M	0.0%	-21.6%	1.008%
5/19/2021	Worth Venture Partners LLC	214,242	$1.89M	0.9%	N/A	0.848%
5/17/2021	Schonfeld Strategic Advisors LLC	54,488	$0.48M	0.0%	N/A	0.216%
5/17/2021	Perceptive Advisors LLC	254,664	$2.25M	0.0%	-21.6%	1.008%
5/17/2021	Caas Capital Management LP	273,210	$2.41M	0.0%	+53.4%	1.082%
5/17/2021	Sphera Funds Management LTD.	323,348	$2.85M	0.2%	-30.9%	1.280%
5/17/2021	Novo Holdings A S	2,459,021	$21.69M	0.9%	-16.9%	9.737%
5/17/2021	Goldman Sachs Group Inc.	12,805	$0.11M	0.0%	-21.9%	0.051%
5/14/2021	Weiss Multi Strategy Advisers LLC	26,573	$0.23M	0.0%	-13.7%	0.105%
5/13/2021	Renaissance Technologies LLC	37,081	$0.33M	0.0%	+78.5%	0.147%
5/13/2021	Bank of New York Mellon Corp	32,303	$0.29M	0.0%	-5.7%	0.128%
5/12/2021	Northern Trust Corp	94,945	$0.84M	0.0%	-3.9%	0.376%
5/12/2021	Geode Capital Management LLC	116,266	$1.03M	0.0%	+2.2%	0.460%
5/12/2021	Panagora Asset Management Inc.	36,144	$0.32M	0.0%	+7.2%	0.143%
5/12/2021	UBS Group AG	4,349	$38K	0.0%	+122.3%	0.017%
5/7/2021	BlackRock Inc.	591,727	$5.22M	0.0%	+10.2%	2.343%
2/25/2021	Hsbc Holdings PLC	13,274	$0.14M	0.0%	N/A	0.053%
2/19/2021	JPMorgan Chase & Co.	22,564	$0.23M	0.0%	+262.1%	0.090%
2/16/2021	Squarepoint Ops LLC	12,428	$0.13M	0.0%	N/A	0.050%
2/12/2021	Caas Capital Management LP	178,141	$1.82M	0.0%	N/A	0.714%
2/11/2021	Northern Trust Corp	98,763	$1.01M	0.0%	-5.0%	0.396%
2/11/2021	Frazier Management LLC	241,000	$2.47M	0.2%	N/A	0.966%
2/10/2021	Renaissance Technologies LLC	20,770	$0.21M	0.0%	+58.9%	0.083%
2/10/2021	Panagora Asset Management Inc.	33,731	$0.35M	0.0%	+4,795.6%	0.135%
2/9/2021	Wells Fargo & Company MN	34,611	$0.35M	0.0%	+407.9%	0.139%
2/9/2021	Bank of New York Mellon Corp	34,273	$0.35M	0.0%	+42.0%	0.137%
2/8/2021	New York State Common Retirement Fund	8,800	$90K	0.0%	+1,000.0%	0.035%
2/5/2021	BlackRock Inc.	536,965	$5.49M	0.0%	+27.1%	2.152%
2/4/2021	State of Wisconsin Investment Board	12,300	$0.13M	0.0%	N/A	0.049%
2/2/2021	Taylor Wealth Management Partners	64,753	$0.66M	0.3%	+4.2%	0.260%
11/17/2020	VR Adviser LLC	51,653	$0.47M	0.1%	N/A	0.207%
11/13/2020	Morgan Stanley	2,777	$25K	0.0%	-52.1%	0.011%
11/10/2020	State Street Corp	82,772	$0.75M	0.0%	-3.1%	0.333%
11/6/2020	BlackRock Inc.	422,640	$3.82M	0.0%	+6.4%	1.699%

Data available starting January 2016

Galera Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule dismutase mimetic for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC); for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; and for patients with HNC undergoing standard-of-care radiotherapy. It also develops rucosopasem manganese (rucosopasem) to augment the anti-cancer efficacy of stereotactic body radiation therapy in patients with non-small cell lung cancer and locally advanced pancreatic cancer. The company was incorporated in 2012 and is based in Malvern, Pennsylvania.

Today's Range

Now: $0.04

$0.04

50 Day Range

MA: $0.06

$0.04

$0.08

52 Week Range

Now: $0.04

$0.04

$0.29

Volume

26,576 shs

Average Volume

67,128 shs

Market Capitalization

$2.12 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.99

Who are the company insiders with the largest holdings of Galera Therapeutics?: Galera Therapeutics' top insider investors include:
Mel Sorensen (CEO)
Mark Bachleda (Insider)
Chris Degnan (CFO)
Learn More about top insider investors at Galera Therapeutics.